CLINICAL_TRIALS
trial_result
· 2020-07-07
Clinical Trial Update: Endothelial Cell Loss After Penetrating Keratoplasty [Phase 2, Phase 3]
Summary
Clinical trial update on endothelial cell loss after penetrating keratoplasty in keratoconus, with Phase 2 and Phase 3 completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Alexandria University | Conditions: Keratoconus | Phase 2, Phase 3 | Status: COMPLETED